Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Genmab A/S
Management change announced at biotech company following CFO's resignation
May 14th, 2003
Genmab A/S announced that chief financial officer Michael Wolff Jensen has resigned in order to take up a position as chief financial officer in a start-up Danish biotech, which is not a competitor to Genmab. Michael Wolff Jensen will leave his position at Genmab on August 1, 2003. Genmab has initiated a procedure to find a replacement CFO, and has put in place a structure for the interim period until a new CFO is announced. During this time the overall responsibility for the finance department will be under the direction of Genmab's CEO, Lisa N. Drakeman. Investor Relations will continue to be handled by VP for IR & PR Rachel...
Source: Biotech Week (2003-05-14)
|
